(S)-4,11-二乙基-4-羟基-3,14-二氧代-3,4,12,14-四氢-1H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-9-基 [1,4'-二哌啶]-1'-羧酸酯盐酸盐
(S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride
盐酸依列替康;盐酸伊立替康;盐酸依立替康;伊立替康;伊利替康;盐酸伊立替康 Irinotecan hydrochloride;盐酸伊立替康(P);盐酸伊立替康,Irinotecan HCL,植物提取物,标准品,对照品;盐酸伊立替康对照品;盐酸伊立替康三水化合物;伊立替康盐酸盐;2-[(11BS)-3,5-二氢-4H-二萘并[2,1-C:1,2-e〕膦-4-基]乙基]胺;2-[(11BS)-3,5-二氢-4H-二萘并[2,1-C:1'',2''-e〕膦-4-基]乙基]胺 盐酸依列替康;盐酸伊立替康;盐酸依立替康;伊立替康;伊利替康;盐酸伊立替康 Irinotecan hydrochloride;盐酸伊立替康(P);盐酸伊立替康,Irinotecan HCL,植物提取物,标准品,对照品;盐酸伊立替康对照品;盐酸伊立替康三水化合物;伊立替康盐酸盐;2-[(11BS)-3,5-二氢-4H-二萘并[2,1-C:1,2-e〕膦-4-基]乙基]胺;2-[(11BS)-3,5-二氢-4H-二萘并[2,1-C:1'',2''-e〕膦-4-基]乙基]胺 展开
100286-90-6
中文名称 (S)-4,11-二乙基-4-羟基-3,14-二氧代-3,4,12,14-四氢-1H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-9-基 [1,4'-二哌啶]-1'-羧酸酯盐酸盐
中文别名 盐酸依列替康;盐酸伊立替康;盐酸依立替康;伊立替康;伊利替康;盐酸伊立替康 Irinotecan hydrochloride;盐酸伊立替康(P);盐酸伊立替康,Irinotecan HCL,植物提取物,标准品,对照品;盐酸伊立替康对照品;盐酸伊立替康三水化合物;伊立替康盐酸盐;2-[(11BS)-3,5-二氢-4H-二萘并[2,1-C:1,2-e〕膦-4-基]乙基]胺;2-[(11BS)-3,5-二氢-4H-二萘并[2,1-C:1'',2''-e〕膦-4-基]乙基]胺
英文名称 (S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride
英文别名 Irinotecan HCL;Irinotecan, Hydrochloride, Trihydrate;Irinotecan Hydrochloride;(S)-[1,4'-Bipiperidine]-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride;(S)-4,11-DIETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL ESTER;TOPOTECIN HYDROCHLORIDE;CPT 11;Irinotecan;Irinotecan (hydrochloride);Irinotecan HCL Trihydrate;IRINOTECAN HCL(P);IRINOTECAN MONOHYDROCHLORIDE TRIHYDRATE;Campto;Campto hydrochloride;Camptothecin 11 hydrochloride;Camptothecin analog;CPT 11 hydrochloride;CPT-11 hydrochloride;Topotecin;Camptosar;Camptothecin 11;U 101440E;06X131E4OE;NSC616348;Irinotecan hydrochloride [USAN:JAN];DSSTox_RID_81249;DSSTox_CID_25953;DSSTox_GSID_45953;Irinotecan hydrochloride;1-[1-({[(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl]oxy}carbonyl)piperidin-4-yl]piperidin-1-ium chloride;MFCD01862255;100286-90-6;NCGC00095190-01;HY-16562A;GURKHSYORGJETM-WAQYZQTGSA-N;AKOS015901921;NSC759878;IRINOTECAN HYDROCHLORIDE [WHO-DD];(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride;(1,4'-Bipiperidine)-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, monohydrochloride;Irinomedac;Z1541760033;CAS-100286-90-6;(1,4'-Bipiperidine)-1'-carboxylic acid, 3,4,12,14-tetrahydro-4,11-diethyl-4-hydroxy-3,4-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, monohydrochloride, (S)-;Irinotecan Hydrochloride100 mg/5 mL;AS-13304;SR-01000763864;CHEBI:5971;Q27106952;(1,4'-BIPIPERIDINE)-1'-CARBOXYLIC ACID, (4S)-4,11-DIETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-9-YL ESTER, HYDROCHLORIDE (1:1);(+)-7-ETHYL-10-HYDROXYCAMPTOTHECINE 10-(1,4'-BIPIPERIDINE)-1'-CARBOXYLATE, MONOHYDROCHLORIDE;IRINOTECAN HYDROCHLORIDE (MART.);(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl[1,4'-bipiperidine]-1'-carboxylatehydrochloride;[1,4'-Bipiperidine]-1'-carboxylic acid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride;SCHEMBL4033;HMS1922J04;(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride;U-101440E;1-(1-((((4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl)oxy)carbonyl)piperidin-4-yl)piperidin-1-ium chloride;(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano(3',4':6,...
CAS No. 100286-90-6
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS